Jenkins v. Price Waterhouse Long Term Disability Plan

564 F.3d 856, 46 Employee Benefits Cas. (BNA) 2404, 2009 U.S. App. LEXIS 9429, 2009 WL 1175171
CourtCourt of Appeals for the Seventh Circuit
DecidedMay 4, 2009
Docket08-1909
StatusPublished
Cited by63 cases

This text of 564 F.3d 856 (Jenkins v. Price Waterhouse Long Term Disability Plan) is published on Counsel Stack Legal Research, covering Court of Appeals for the Seventh Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Jenkins v. Price Waterhouse Long Term Disability Plan, 564 F.3d 856, 46 Employee Benefits Cas. (BNA) 2404, 2009 U.S. App. LEXIS 9429, 2009 WL 1175171 (7th Cir. 2009).

Opinion

EVANS, Circuit Judge.

In 1989, when he was 27 years old, Charles Jenkins started working as a “Senior Account Consultant” for PricewaterhouseCoopers LLP (PwC). His tenure with the company was cut short four years later when he ceased working due to HIV. In 1994, he started receiving long-term disability benefits under a PwC plan governed by the Employee Retirement Income Security Act (ERISA), 29 U.S.C. § 1001 et seq. After making payments for a decade, PwC had second thoughts. Despite a terminal illness that kept him sidelined for more than 10 years, PwC — or, more accurately, the plan administrator, Connecticut General Life Insurance Company (CGLIC) — decided Jenkins could do some work so it cut off his benefits. Jenkins appeals from the district court’s order affirming that decision.

When HIV (the virus that causes AIDS) was first reported in the United States in the early 1980s, it was viewed as a death sentence, and a quick one at that. That was probably an exaggeration, but not a ridiculous one. See Andrew Sullivan, Fighting the Death Sentence, N.Y. Times, Nov. 21, 1995, at A21 (discussing the state of HIV/AIDS treatment and society’s view of the disease in the early years). Without treatment, a person who is HIV-positive lives on average only 11 years after infection. World Health Organization & UNAIDS, AIDS Epidemic Update, at 10 (December 2007), available at http://data. unaids.org/pub/EPISlides/2007/2007_ epiupda te_en.pdf. But new medicines (where available 1 ) have slashed the death rate and raised the life expectancy of a diagnosed individual dramatically. “A patient diagnosed at 20 today can expect to live to nearly 70, research shows. At 35— the average age of diagnosis in the UK— life expectancy is over 72.” Jeremy Laurance, New Drugs Raise Life Expectancy of HIV Sufferers by IS Years, The Independent (July 25, 2008). So, while HIV remains a grave disease — and no cure has yet been found — things have improved. Jenkins is hopefully benefitting from these advances. 2

*858 Jenkins tested positive for HIV in 1988, but he didn’t have serious problems until 1993. By the end of the year, he was no longer able to work. His symptoms included extreme fatigue, lower extremity neuropathy (nerve damage), decreased sensation in his fingers, bilateral manual dexterity limitations, and other opportunistic infections including condylomata (genital warts), myositis (muscle inflammation), and allergic rhinitis (more commonly known as a runny nose).

Jenkins filed a claim under PwC’s Long Term Disability Plan (LTD plan), which was underwritten and administered by CGLIC. He alleged that he met the plan definition of “total disability” — inability to perform one’s own occupation and, later, to perform any occupation within one’s qualifications 3 — and CGLIC agreed. Beginning in June 1994, CGLIC paid Jenkins $2,550 per month, or 60 percent of his salary. When the Social Security Administration awarded benefits 4 on top of that, CGLIC reduced its monthly payments by an equal amount, meaning the net pay to Jenkins remained the same. And when the “total disability” standard shifted in 1999, CGLIC confirmed that Jenkins could not work any job for which he was qualified, and so he continued to receive benefits without interruption. Thus it went until January 2006, when Jenkins’s benefits were terminated.

For some reason, CGLIC decided to take a second look at Jenkins’s claim beginning in late 2004. (The record doesn’t indicate what aroused CGLIC’s suspicions, but one possibility is that CGLIC got wind of the fact that Jenkins went on a sojourn to London a year earlier, a venture arguably at odds with his medical limitations.) The medical evidence up to that point supported Jenkins’s claim. Just before he stopped work in 1993, Jenkins met with an AIDS specialist, Dr. Steven M. Pounders, who concluded he suffered from “significant fatigue and advanced HIV infection” such that his current job was not sustainable. One month later, Jenkins’s CD4 T-cell count was measured at just 155 cells per microliter of blood; anyone with a count lower than 200 is considered to have AIDS by the Centers for Disease Control and Prevention. Eileen Schneider, et ah, Revised Surveillance Case Definitions for HIV Infection Among Adults, Adolescents, and Children (December 2008), available at http://www.cdc.gov/mmwr /preview/mmwrhtml/rr5710al.htm?s_cid=r r5710al_e. Pounders diagnosed Jenkins with AIDS shortly thereafter-also noting the development of anal fissures and in *859 creased pain — and determined that Jenkins was incapable of even minimal sedentary activity. In fact, Pounders concluded Jenkins would “never” return to work of any kind. Pounders maintained this position until he transferred Jenkins’s case to Dr. David J. Prelutsky, Jenkins’s current treating physician, in 1997.

Dr. Prelutsky echoed the prior findings in a disability form submitted in April of 1997, noting limitations in standing, walking, climbing, bending, lifting, and psychological functions. Like Pounders, Prelutsky thought Jenkins would never return to work — even a trial period was out of the question. At the time, CGLIC basically agreed. In a 1999 internal assessment, CGLIC categorized Jenkins’s situation as a “stable and mature claim” in that his “condition was deteriorating with no chance of improvement....”

Five years later, though, CGLIC began to question that assessment. (Again, the timing suggests that the London trip may have been the impetus.) CGLIC asked Dr. Scott Taylor to look into things and, after reviewing Jenkins’s file and speaking with Dr. Prelutsky, Taylor concluded that there was not “adequate clinical information or medical documentation” to support the disability claim. Taylor conceded that Jenkins had a low T-cell count but emphasized that it was “stable.” Further, Taylor observed that the “viral load” was “undetectable” as of December 2003, and he discounted Jenkins’s complaints of fatigue and poor concentration for lack of objective evidence.

For the time being, nevertheless, CGLIC continued to pay Jenkins his benefits. That wouldn’t last long. In January 2005, CGLIC had Dr. Barry Kern do an additional review. Like Taylor, Kern did not meet with Jenkins, but rather reviewed his medical records and spoke with Dr. Prelutsky. Kern observed that, although Jenkins’s weight and T-cell count had fluctuated considerably over the years, he always weighed over 200 pounds and his T-cell count had stabilized “at about 100.” Dr. Kern concluded, “From a functional perspective, the HIV would not prevent [Jenkins] from performing full time light duty or sedentary work.”

The next step was an independent medical examination (IME) performed by Dr. Karen Shockley. 5 Dr. Shockley met with Jenkins for an IME in June 2005. Jenkins described his medical history, explaining that in addition to fatigue and rectal pain, he suffered over the years from chronic bronchitis, sinus infections, and nausea.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Berceanu, Luciana v. UMR, Inc.
W.D. Wisconsin, 2023
Fountain v. Zimmer Inc.
N.D. Indiana, 2021

Cite This Page — Counsel Stack

Bluebook (online)
564 F.3d 856, 46 Employee Benefits Cas. (BNA) 2404, 2009 U.S. App. LEXIS 9429, 2009 WL 1175171, Counsel Stack Legal Research, https://law.counselstack.com/opinion/jenkins-v-price-waterhouse-long-term-disability-plan-ca7-2009.